Coley’s Lessons Remembered
Authors:
Open Access
- 26 July 2016
- journal article
- review article
- Published by SAGE Publications in Integrative Cancer Therapies
- Vol. 15 (4) , 502-511
Abstract
The following four observations point in the same direction, namely that there is an unleveraged potential for stimulating the innate immune system against cancer: (1) experimental treatments with bacterial extracts more than 100 years ago by Coley and contemporaries, (2) a positive correlation between spontaneous regressions and febrile infection, (3) epidemiological data suggesting an inverse correlation between a history of infection and the likelihood of developing cancer, and (4) our recent finding that a cocktail of pattern recognition receptor ligands (PRRLs) can eradicate solid tumors in cancer mice if applied metronomically. Because the main immunostimulating component of mistletoe extract (ME), mistletoe lectin, has been shown to be a PRRL as well, we suggest to apply ME in combination with additional PRRLs. Additional PRRLs can be found in approved drugs already on the market. Therefore, augmentation of ME might be feasible, with the aim of reattaining the old successes using approved drugs rather than bacterial extracts.Keywords
This publication has 54 references indexed in Scilit:
- TLR agonists: our best frenemy in cancer immunotherapyJournal of Leukocyte Biology, 2013
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- TLR4-mediated activation of mouse macrophages by Korean mistletoe lectin-C (KML-C)Biochemical and Biophysical Research Communications, 2010
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response CriteriaClinical Cancer Research, 2009
- Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical researchJournal of Experimental & Clinical Cancer Research, 2009
- Tumor Cell Loaded Type-1 Polarized Dendritic Cells Induce Th1-Mediated Tumor ImmunityCancer Research, 2005
- Cancer Outcomes at the Hufeland (Complementary/Alternative Medicine) Klinik: A Best-Case Series ReviewIntegrative Cancer Therapies, 2005
- A type I interferon autocrine–paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cellsJournal of Experimental Medicine, 2005
- TEMPERATURE RANGE AND SELECTIVE SENSITIVITY OF TUMORS TO HYPERTHERMIA: A CRITICAL REVIEWAnnals of the New York Academy of Sciences, 1980
- HYPERTHERMIA IN THE TREATMENT OF CANCERThe Lancet, 1979